HAL vs IONS · P/E 9.3, $19.05B cap vs rev $226.6M
Halliburton Company (HAL) versus Ionis Pharmaceuticals Inc (IONS) — a side-by-side from cached financials, not a winner call.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
HAL does not have a complete income-statement cache yet.
Latest reported IONS revenue for 2024-12-31 was $226.6M. Net income was -$104.3M. Revenue was down 30.2% from 2023-12-31 to 2024-12-31. IONS currently screens at market cap $12.28B.
HAL currently screens at market cap $19.05B and trailing P/E 9.3. IONS currently screens at market cap $12.28B.
Not investment advice. Open the HAL and IONS stock pages for the full models.
Not investment advice.